PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Prolia
- Generic name / active ingredient
- denosumab
- Dosage-form class
- Subcutaneous injection(60 mg/mL single-doseprefilled syringe; as listed in the 2025 FDA label)
- Route
- Subcutaneous injection
- Record reviewed
- 2026-08-16
Copy from the pack in hand
Source-linked reading points
- The label's “60 mg/mL single-dose prefilled syringe” describes strength, concentration and package form together. It does not determine when any individual should be injected, whether it can be advanced or delayed, or whether another injectable can replace it.
- The label identifies hypocalcaemia, kidney-related risk and assessment before initiation as important matters. Especially with advanced chronic kidney disease, recent test changes or multiple medicines, do not independently start, delay, stop or add products from a webpage, package or past routine alone.
- The label states that people receiving PROLIA should not also receive another denosumab product. This is a safety check requiring the complete medicine list and exact product, not a basis for self-deciding whether another medicine is “the same ingredient” or for self-switching or stopping.
- Photos, syringe colour and package wording only help locate a source. Markets, label versions and packages can differ; an image cannot authenticate a product, confirm current approval or replace prompt medical assessment for symptoms such as spasms, tingling or severe illness.
Reviewed presentation examples — compare every field
- 60 mg/1 mL (60 mg/mL); one single-dose prefilled-syringe cartonNDC 55513-710-21